It is our pleasure to invite you to participate in The 2nd World Congress on Clinical Trials in Diabetes (WCTD2017), which will take place 27-28 November 2017 in Berlin, Germany.
WCTD2017 follows the success of the 1st inaugural Congress held in Berlin in November 2016 and will continue to address the multitude of complex issues associated with clinical trials in diabetes.
It is clear that there is a continuing necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them.
Once again, our world renowned faculty will tackle issues head, on through a comprehensive program which will focus on key areas including:
- Design the Best Study
- Improve Regulatory Process
- Better Understanding of How to Collaborate with Regulatory Authorities
- Involvement of Digital Medicine
- Management of Diabetes and Personalized Medicine
The scientific program will have a broad therapeutic focus and tackle both the global and specific regional differences. The program will include speakers such as physicians, R&D personnel, regulatory decision makers, CEOs, CROs, CRAs, Clinical Trial Managers and QA personnel.
You are invited and encouraged to contribute to the program by submitting abstracts for poster presentation and we look forward to your active involvement.
We look forward to seeing you at WCTD2017 in the exciting and historical city of Berlin, which provides an unforgettable backdrop for the Congress.
Prof. Itamar Raz Bioevents
Congress Chair Congress Organizer
The congress is conducted in collaboration with the D-Cure Foundation.
WCTD2017 was generously supported by D-Cure.